Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page
- Check5 days agoChange DetectedThe VIP152 Phase I study record is available, describing the trial’s treatment arms, participant criteria, outcome measures, and study locations. The record indicates the study is completed and is no longer recruiting participants.SummaryDifference72%

- Check12 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check26 days agoChange DetectedA general NIH notice about terminology during a website transition was added, and the site revision changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check47 days agoChange DetectedFull study details and metadata are now visible on the page, including the overview, design, eligibility criteria, enrollment locations, outcomes, and related MeSH terms and sponsor information. Previously, the page displayed a 403 Forbidden error, blocking access to this content.SummaryDifference74%

- Check54 days agoChange DetectedThe page now renders a 403 Forbidden error page, indicating access to the study record is blocked, with a minimal header and a Home link. The original study content and related items have been removed.SummaryDifference20%

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.